Molnupiravir has serious safety concerns: ICMR chief
“The Indians are correct it is a shit drug which is criticised by many as maybe creating harmful variants. Also other undamaged damage. With very low efficiency.” – Dr Zioni
NEW DELHI: Antiviral drug molnupiravir, which recently got approval from the drug regulator and is being launched by several local drug makers, has serious safety concerns, and thus has not been included in the national Covid-19 clinical protocol recommended by the health ministry, the Indian Council of Medical Research (ICMR) director general Balram Bhargava said.
Bhargava said the Covid-19 task force has debated whether to include the drug in the Covid-19 treatment protocol but decided against it because of concerns.
Those who are not really at high risk and older, it is better to avoid.